ALK inhibition in two emblematic cases of pediatric inflammatory myofibroblastic tumor: Efficacy and side effects-Reference-Cited by-同舟云学术

ALK inhibition in two emblematic cases of pediatric inflammatory myofibroblastic tumor: Efficacy and side effects

Published:2019-01-29 Issue:5 Volume:66 Page:e27645
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Brivio Erica¹^ORCID,Zwaan C. Michel¹²

Affiliation:

1. Prinses Maxima CentrumCenter for Pediatric Oncology Utrecht the Netherlands

2. Department of Pediatric Oncology/HematologyErasmus MC‐Sophia Children's Hospital Rotterdam the Netherlands

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.27645

Reference15 articles.

1. European Medicines Agency.Paediatric strategy forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies. EMA/210027/2017 Report.2017.

2. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children’s Oncology Group Study

3. Inflammatory myofibroblastic tumours: where are we now?

4. Crizotinib in ALK+inflammatory myofibroblastic tumors-Current experience and future perspectives

5. Chromoplectic TPM3–ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endobronchial Inflammatory Myofibroblastic Tumour Masquerading as a Ruptured Hydatid Cyst;Cureus;2024-04-15

2. Rare inflammatory myofibroblastic lung tumor with multi-organ metastasis: A case report;Journal of Modern Oncology;2024-02-21

3. Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment;Oncology Research;2024

4. Update of Diagnosis and Targeted Therapy for ALK+ Inflammation Myofibroblastic Tumor;Current Treatment Options in Oncology;2023-11-08

5. Rezeptor-Tyrosinkinase-Fusionen in spindelzelligen Tumoren des Kindesalters;Die Pathologie;2023-10-11